This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Thomson Reuters-NPR Health Poll Finds Three In Four Americans Link Narcotic Pain Killers To Drug Addiction













ANN ARBOR, Mich. and WASHINGTON, Nov. 22, 2011 /PRNewswire/ -- More than three-quarters of Americans believe narcotic pain killers are linked to drug addiction and 59.5 percent associate the drugs with depression, according to the Thomson Reuters-NPR Health Poll.

Thomson Reuters and NPR conduct the monthly poll to gauge attitudes and opinions on a wide range of health issues.

The survey, which asked respondents their opinions and concerns regarding narcotic pain killers, found that 49.7 percent have used these drugs in the past.  Of those, over one-third of respondents said they used the drugs despite having concerns regarding their use.  The top concerns reported were potential side effects (44.9 percent), fear of addiction (27.5 percent) and concern about potential long-term health impacts (15.5 percent).

Among all survey respondents (those who have taken narcotic pain killers and those who have not), 77.2 percent said they believe the use of narcotic pain killers such as Oxycontin, Percocet, Vicodin or morphine can lead to drug abuse and 59.5 percent said they associated the drugs with depression.  Additionally, 30.8 percent of survey respondents said they questioned or refused a physicians recommendation of narcotic pain killers.  Those who have not taken narcotic pain killers in the past cited fear of addiction as their primary concern (38 percent), followed by association with drug abuse (24.8 percent) and side effects (20.8 percent).

"With such a significant number of responders having been prescribed a narcotic pain killer, our results suggest that these drugs are relatively easy to access despite the need for a physician's prescription," said Raymond Fabius, M.D., chief medical officer at the healthcare business of Thomson Reuters. "It's encouraging to see a healthy understanding of the addictive properties of narcotics among our survey population, but refusing to use them when they can be helpful may cause people to experience unnecessary pain."

To date, the Thomson Reuters-NPR Health Poll has explored numerous healthcare topics, including generic drugs, abortion, vaccines, food allergies, and organic and genetically modified foods. NPR's reports on the surveys are archived online at the Shots health blog here: http://www.npr.org/blogs/health/2011/11/22/142601714/when-weighing-painkillers-americans-worry-will-i-become-an-addict?ps=sh_sthdl

Thomson Reuters maintains a library of poll results: http://healthcare.thomsonreuters.com/npr/

The Thomson Reuters-NPR Health Poll is powered by the Thomson Reuters PULSE(SM) Healthcare Survey, an independently funded, nationally representative telephone poll that collects information about health-related behaviors and attitudes and healthcare utilization from more than 100,000 US households annually. Survey questions are developed in conjunction with NPR. The figures in this month's poll are based on 3,009 participants interviewed from October 1-13, 2011. The margin of error is 1.8 percent.

For a copy of the vaccine survey results. visit http://healthcare.thomsonreuters.com/npr/assets/NPR_report_PainKillers.pdf

About Thomson ReutersThomson Reuters is the world's leading source of intelligent information for businesses and professionals.  We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization.  With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 55,000 people and operates in over 100 countries.  For more information, go to www.thomsonreuters.com.

About NPRNPR is an award-winning, multimedia news organization and an influential force in American life. In collaboration with more than 900 independent public radio stations nationwide, NPR strives to create a more informed public - one challenged and invigorated by a deeper understanding and appreciation of events, ideas and cultures.

 

Stock quotes in this article: TRI 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASDAQ 4,126.9670 -34.4910 -0.83%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs